World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
51
Citations
19007
World Ranking
2466
National Ranking
1215

Overview

Jason Roszik is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research output primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a strong focus on oncology and related disciplines.

The scientist's work covers a range of subfields including Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, and Immunology. Their main research topics involve Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Lung Cancer Treatments and Mutations, Immunotherapy and Immune Responses, and Peptidase Inhibition and Analysis.

Jason Roszik has contributed to multiple high-profile journals, with frequent publications in:

  • Cancer Research
  • Journal of Clinical Oncology
  • Cancers
  • Molecular Cancer Therapeutics
  • Clinical Cancer Research

Their recent papers include:

  • "Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response" (2021, Science)
  • "Immuno-genomic landscape of osteosarcoma" (2020, Nature Communications)
  • "The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies" (2020, Molecular Cancer Therapeutics)
  • "Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches" (2021, Cancer Discovery)
  • "Pan-Cancer Efficacy of Vemurafenib in BRAF V600-Mutant Non-Melanoma Cancers" (2020, Cancer Discovery)

Frequent coauthors who have collaborated with Jason Roszik include Vivek Subbiah, Funda Meric-Bernstam, David S. Hong, Aung Naing, and Elizabeth A. Grimm.

Best Publications

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Weiyi Peng;Jie Qing Chen;Chengwen Liu;Shruti Malu

  • Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy

    Jianjun Gao;Lewis Zhichang Shi;Hao Zhao;Jianfeng Chen

  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

    Adam Abeshouse;Clement Adebamowo;Sally N. Adebamowo;Rehan Akbani

  • Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma

    A. Gordon Robertson;Juliann Shih;Juliann Shih;Christina Yau;Ewan A. Gibb

  • Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

    Whijae Roh;Pei Ling Chen;Alexandre Reuben;Christine N. Spencer

  • Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.

    Tina Cascone;Jodi A. McKenzie;Rina M. Mbofung;Simone Punt

  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers

    Ashton C Berger;Anil Korkut;Rupa S Kanchi;Apurva M Hegde

  • The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

    Leng Han;Lixia Diao;Shuangxing Yu;Xiaoyan Xu;Xiaoyan Xu

  • mTORC2 Promotes Tumorigenesis via Lipid Synthesis.

    Yakir Guri;Marco Colombi;Eva Dazert;Sravanth K. Hindupur

  • NLRC5/MHC class I transactivator is a target for immune evasion in cancer

    Sayuri Yoshihama;Jason Roszik;Isaac Downs;Torsten B. Meissner

  • Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection

    Pappanaicken R. Kumaresan;Pallavi R. Manuri;Nathaniel D. Albert;Sourindra Maiti

  • Mechanisms of nuclear content loading to exosomes

    Akira Yokoi;Alejandro Villar-Prados;Alejandro Villar-Prados;Paul Allen Oliphint;Jianhua Zhang

  • Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780–2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033))

    Vincenzo Cardinale;Eugenio Gaudio;Domenico Alvaro;Antonio Franchitto

  • Immuno-genomic landscape of osteosarcoma

    Chia Chin Wu;Hannah C. Beird;J. Andrew Livingston;Shailesh Advani

  • Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma

    Peter Bailey;David K. Chang;Marie Andreé Forget;Francis A.San Lucas

  • Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy.

    Yiliang Li;Sapna Pradyuman Patel;Jason Roszik;Yong Qin

  • A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

    Anil Korkut;Sobia Zaidi;Rupa S. Kanchi;Shuyun Rao

  • Beyond BRAFV600: Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma

    Alan E. Siroy;Genevieve M. Boland;Denái R. Milton;Jason Roszik

  • Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma (vol 32, pg 204, 2017)

    A.G. Robertson;J.L. Shih;C. Yau;E.A. Gibb

Frequent Co-Authors

Patrick Hwu
Patrick Hwu The University of Texas MD Anderson Cancer Center
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center
Elizabeth A. Grimm
Elizabeth A. Grimm The University of Texas MD Anderson Cancer Center
Chantale Bernatchez
Chantale Bernatchez The University of Texas MD Anderson Cancer Center
Michael A. Davies
Michael A. Davies The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Cara Haymaker
Cara Haymaker The University of Texas MD Anderson Cancer Center
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Jennifer A. Wargo
Jennifer A. Wargo The University of Texas MD Anderson Cancer Center
Shreyaskumar Patel
Shreyaskumar Patel The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology often leads to diverse and rewarding career possibilities. Many students consider related online degrees—such as in History, Library Science, or Speech-Language Pathology (SLP)—as alternative or complementary pathways.

For example, those exploring job outlooks may wonder how much do historians make after completing a graduate degree. Similarly, students interested in information science may look at the cost of mlis degree us to evaluate educational investment versus career potential.

In healthcare, SLP remains popular due to its demand and clear career pathways. Prospective SLPs should make sure to choose asha accredited slp programs, ensuring program quality and eligibility for certification. Additionally, if your background is outside of SLP, there are convenient speech pathology bridge programs that help transition from other science majors.

Exploring these related degrees can broaden your options and help you find a fulfilling career path that aligns with your interests in molecular science and research.

Best Scientists Citing Jason Roszik

Trending Scientists